Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related HTWR
Keep An Eye On This New Activist Hedge Fund Managed By Former JPMorgan Executives
HeartWare Terminates Proposed Acquisition of Valtech Cardio
Related MSFT
PacCrest Analysts Lower PC OEM Estimates En Masse
Kevin Kelly's Microsoft Corporation Trade
SPYRUS Achieves Industry-Leading One-Terabyte USB 3.0 SSD Bootable Windows To Go Devices (GuruFocus)

Analysts at Goldman Sachs downgraded Heartware International (NASDAQ: HTWR) from “neutral” to “sell.” The target price for Heartware International has been lowered from $94 to $73. Heartware's shares closed at $81.26 on Friday.

Analysts at Deutsche Bank downgraded Microsoft (NASDAQ: MSFT) from “buy” to “hold.” The target price for Microsoft is set to $42. Microsoft's shares closed at $39.21 on Friday.

Morgan Stanley downgraded Mindray Medical International (NYSE: MR) from “overweight” to “equal-weight.” The target price for Mindray Medical has been lowered from $44 to $37. Mindray Medical's shares closed at $33.08 on Friday.

Analysts at Credit Suisse downgraded Enbridge (NYSE: ENB) from “outperform” to “neutral.” Enbridge's shares closed at $46.60 on Friday.

Latest Ratings for HTWR

DateFirmActionFromTo
Jan 2016Raymond JamesUpgradesMarket PerformOutperform
Jan 2016
Oct 2015Piper JaffrayDowngradesOverweightNeutral

View More Analyst Ratings for HTWR
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (HTWR + ENB)

Get Benzinga's Newsletters